Michael Chambers is an angel investor and operator angel based in Fargo, North Dakota, United States. The known portfolio counts 3 companies: Kytopen, 64x Bio and Erbi Biosystems.
Is Michael Chambers a fit for your startup?
Paste your website. AI checks the fit and scores every other investor too.
Investment focus
- Stage
- Seed
- Sector
- Healthcare
Contacts
Michael Chambers portfolio companies (3)
- Kytopen
- 64x Bio
- Erbi Biosystems
Investor Profile
Founders in the listed sector Healthcare, and focus areas Biotech, Genomics, Life Science and Pharmaceuticals will recognize the pattern in this portfolio.
Stage-wise, the known deals cluster around Seed rounds.
The portfolio and focus above give founders context on whether Michael Chambers matches their raise.
Similar investors
Showing 19 of 99
Frequently asked questions
Who is Michael Chambers?
Michael Chambers is an angel investor and operator angel based in Fargo, North Dakota, United States with 3 known investments on file, among them Kytopen, 64x Bio and Erbi Biosystems. The sections above list the sectors and stages attached to that record.
What does Michael Chambers invest in?
Listed sectors include Healthcare; listed focus areas include Biotech, Genomics, Life Science and Pharmaceuticals. Those tags come from the companies attached to this profile, so they read as a record of what has been backed rather than a stated preference for what comes next.
What stage does Michael Chambers invest at?
The known deals of Michael Chambers include Seed rounds. Stage is the strongest single filter when you build a target list: an investor with no record at your stage rarely starts with you.
How do I contact Michael Chambers?
An email address, a phone number and a LinkedIn page are on file for Michael Chambers. The address stays masked on this page and is readable inside RaiseHunt after you create an account.
Skip the browsing. Let AI find your ideal investors in one minute.
Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.
Data: RaiseHunt investor dataset · Snapshot 5 September 2026 · How this data is built · Report a correction or request removal
